The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
Abstract
The objective was to update previous evidence‐based medicine reviews of treatments for motor symptoms of Parkinson's disease published between 2002 and 2005. Level I (randomized, controlled trial) reports of pharmacological, surgical, and nonpharmacological interventions for the motor symptoms of Parkinson's disease between January 2004 (2001 for nonpharmacological) and December 2010 were reviewed. Criteria for inclusion, clinical indications, ranking, efficacy conclusions, safety, and implications for clinical practice followed the original program outline and adhered to evidence‐based medicine methodology. Sixty‐eight new studies qualified for review. Piribedil, pramipexole, pramipexole extended release, ropinirole, rotigotine, cabergoline, and pergolide were all efficacious as symptomatic monotherapy; ropinirole prolonged release was likely efficacious. All were efficacious as a symptomatic adjunct except pramipexole extended release, for which there is insufficient evidence. For prevention/delay of motor fluctuations, pramipexole and cabergoline were efficacious, and for prevention/delay of dyskinesia, pramipexole, ropinirole, ropinirole prolonged release, and cabergoline were all efficacious, whereas pergolide was likely efficacious. Duodenal infusion of levodopa was likely efficacious in the treatment of motor complications, but the practice implication is investigational. Entacapone was nonefficacious as a symptomatic adjunct to levodopa in nonfluctuating patients and nonefficacious in the prevention/delay of motor complications. Rasagiline conclusions were revised to efficacious as a symptomatic adjunct, and as treatment for motor fluctuations. Clozapine was efficacious in dyskinesia, but because of safety issues, the practice implication is possibly useful. Bilateral subthalamic nucleus deep brain stimulation, bilateral globus pallidus stimulation, and unilateral pallidotomy were updated to efficacious for motor complications. Physical therapy was revised to likely efficacious as symptomatic adjunct therapy. This evidence‐based medicine review updates the field and highlights gaps for research. © 2011 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Self-citationLevodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
Evidence-Based Medicine: How to Practice and Teach EBM
Satya-Murti, S. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.284.18.2382 · Cited by 1,643
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Self-citationWeaver, F. M. (2009) · JAMA · doi:10.1001/jama.2008.929 · Cited by 1,525
Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients
Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., Whetteckey, J., Wunderlich, G. R., & Lang, A. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.65 · Cited by 1,487
Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907083 · Cited by 1,355
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Goodwin, V. A., Richards, S. H., Taylor, R. S., Taylor, A. H., & Campbell, J. L. (2008) · Movement Disorders · doi:10.1002/mds.21922 · Cited by 922 · cited 17×
“Several publications have recently reviewed the challenges of assessing physical therapy as an intervention in PD.(111,112) All studies to date have been for symptomatic adjunctive therapy in PD patients who are at least H&Y stage 1.”
BackgroundInfluentialA Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
Olanow, C. W., Rascol, O., Hauser, R., Feigin, P. D., Jankovic, J., Lang, A., Langston, W., Melamed, E., Poewe, W., Stocchi, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809335 · Cited by 901
Self-citationCueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial
Nieuwboer, A., Kwakkel, G., Rochester, L., Jones, D., van Wegen, E., Willems, A. M., Chavret, F., Hetherington, V, Baker, K., & Lim, I. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.200x.097923 · Cited by 857 · cited 1×
“Nieuwboer et al (2007)99 performed a single-blind crossover multicenter 12-week study in 153 PD patients with gait disturbance of at least 1 on UPDRS item 29 and in H&Y stages 2–4 (RESCUE trial).”
MethodWilliams, A., Gill, S., Varma, T., Jenkinson, C., Quinn, N., Mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70093-4 · Cited by 733
Association of dopamine agonist use with impulse control disorders in Parkinson disease
Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.969 · Cited by 662 · cited 1×
“7%).(32,33) The association with any specific dopamine agonist is unclear because of the variable prescribing habits of clinics and different methods of measuring prevalence rates.”
BackgroundWitt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M. O., Krause, M., Tronnier, V., Kloss, M., Schnitzler, A., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70114-5 · Cited by 651
Rascol, O., Brooks, D., Melamed, E., Oertel, W., Poewe, W., Stocchi, F., & Tolosa, E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71083-7 · Cited by 641
Self-citation(2004) · Archives of Neurology · doi:10.1001/archneur.61.7.1044 · Cited by 561
Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease
Anderson, V. C., Burchiel, K. J., Hogarth, P., Favre, J., & Hammerstad, J. P. (2005) · Archives of Neurology · doi:10.1001/archneur.62.4.554 · Cited by 537
Comparative Effectiveness Research: A Report From the Institute of Medicine
Sox, H. C., & Greenfield, S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-3-200908040-00125 · Cited by 525
A Controlled, Randomized, Delayed-Start Study of Rasagiline in Early Parkinson Disease
(2004) · Archives of Neurology · doi:10.1001/archneur.61.4.561 · Cited by 485
Intensive voice treatment (LSVT(R)) for patients with Parkinson's disease: a 2 year follow up
Ramig, L. O. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.493 · Cited by 481
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease
Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schüpbach, M., D’Ambrosia, J., Thobois, S., Tamma, F., Herzog, J., et al. (2008) · Brain · doi:10.1093/brain/awn214 · Cited by 472
Neurosurgery in Parkinson disease: A distressed mind in a repaired body?
Schüpbach, M., Gargiulo, M., Welter, M. L., Mallet, L., Béhar, C., Houeto, J. L., Maltête, D., Mesnage, V., & Agid, Y. (2006) · Neurology · doi:10.1212/01.wnl.0000234880.51322.16 · Cited by 461
Trenkwalder, C., Kies, B., Rudzinska, M., Fine, J., Nikl, J., Honczarenko, K., Dioszeghy, P., Hill, D., Anderson, T., Myllyla, V., et al. (2011) · Movement Disorders · doi:10.1002/mds.23441 · Cited by 437
Self-citationDuodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
Nyholm, D., Nilsson Remahl, A. I. M., Dizdar, N., Constantinescu, R., Holmberg, B., Jansson, R., Aquilonius, S. M., & Askmark, H. (2005) · Neurology · doi:10.1212/01.wnl.0000149637.70961.4c · Cited by 432
(2005) · Archives of Neurology · doi:10.1001/archneur.62.2.241 · Cited by 418
Poewe, W. H., Rascol, O., Quinn, N., Tolosa, E., Oertel, W. H., Martignoni, E., Rupp, M., & Boroojerdi, B. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70108-4 · Cited by 398
Self-citationGoetz, C. G., Poewe, W., Rascol, O., & Sampaio, C. (2005) · Movement Disorders · doi:10.1002/mds.20464 · Cited by 376
Self-citationStocchi, F., Rascol, O., Kieburtz, K., Poewe, W., Jankovic, J., Tolosa, E., Barone, P., Lang, A. E., & Olanow, C. W. (2010) · Annals of Neurology · doi:10.1002/ana.22060 · Cited by 374
Self-citationAshburn, A., Fazakarley, L., Ballinger, C., Pickering, R., McLellan, L. D., & Fitton, C. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.099333 · Cited by 347
Petzinger, G. M., Walsh, J. P., Akopian, G., Hogg, E., Abernathy, A., Arevalo, P., Turnquist, P., Vučković, M., Fisher, B. E., Togasaki, D. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1069-07.2007 · Cited by 329
Prospective prevalence of pathologic gambling and medication association in Parkinson disease
Voon, V., Hassan, K., Zurowski, M., Duff-Canning, S., de Souza, M., Fox, S., Lang, A. E., & Miyasaki, J. (2006) · Neurology · doi:10.1212/01.wnl.0000218206.20920.4d · Cited by 329
Self-citationProgress in Evidence-Based Medicine
Montori, V. M. (2008) · JAMA · doi:10.1001/jama.300.15.1814 · Cited by 315
Tai Chi improves balance and mobility in people with Parkinson disease
Hackney, M. E., & Earhart, G. M. (2008) · Gait & Posture · doi:10.1016/j.gaitpost.2008.02.005 · Cited by 295
Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease
Pahwa, R., Stacy, M. A., Factor, S. A., Lyons, K. E., Stocchi, F., Hersh, B. P., Elmer, L. W., Truong, D. D., & Earl, N. L. (2007) · Neurology · doi:10.1212/01.wnl.0000258660.74391.c1 · Cited by 290
Selegiline slows the progression of the symptoms of Parkinson disease
Pålhagen, S., Heinonen, E., Hägglund, J., Kaugesaar, T., Mäki-Ikola, O., Palm, R., & the Swedish Parkinson Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000204007.46190.54 · Cited by 271
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
Katzenschlager, R., Head, J., Schrag, A., Ben-Shlomo, Y., Evans, A., & Lees, A. J. (2008) · Neurology · doi:10.1212/01.wnl.0000310812.43352.66 · Cited by 271
Self-citationAdvanced Parkinson disease treated with rotigotine transdermal system: PREFER Study
LeWitt, P. A., Lyons, K. E., & Pahwa, R. (2007) · Neurology · doi:10.1212/01.wnl.0000259516.61938.bb · Cited by 261
Comparing exercise in Parkinson's disease—the Berlin BIG Study
Ebersbach, G., Ebersbach, A., Edler, D., Kaufhold, O., Kusch, M., Kupsch, A., & Wissel, J. (2010) · Movement Disorders · doi:10.1002/mds.23212 · Cited by 253
Hauser, R. A., Rascol, O., Korczyn, A. D., Jon Stoessl, A., Watts, R. L., Poewe, W., De Deyn, P. P., & Lang, A. E. (2007) · Movement Disorders · doi:10.1002/mds.21743 · Cited by 252
Self-citationRandomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease
Watts, R. L., Jankovic, J., Waters, C., Rajput, A., Boroojerdi, B., & Rao, J. (2007) · Neurology · doi:10.1212/01.wnl.0000252355.79284.22 · Cited by 249
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease
Vitek, J. L., Bakay, R. A. E., Freeman, A., Evatt, M., Green, J., McDonald, W., Haber, M., Barnhart, H., Wahlay, N., Triche, S., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10517 · Cited by 243
Ellis, T., de Goede, C. J., Feldman, R. G., Wolters, E. C., Kwakkel, G., & Wagenaar, R. C. (2005) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2004.08.008 · Cited by 242
Lim, S.-Y., O’Sullivan, S. S., Kotschet, K., Gallagher, D. A., Lacey, C., Lawrence, A. D., Lees, A. J., O’Sullivan, D. J., Peppard, R. F., Rodrigues, J. P., et al. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.12.010 · Cited by 240
Self-citationZonisamide improves motor function in Parkinson disease: A randomized, double-blind study
Murata, M., Hasegawa, K., Kanazawa, I., & The Japan Zonisamide on PD Study Group (2007) · Neurology · doi:10.1212/01.wnl.0000250236.75053.16 · Cited by 238
Suchowersky, O., Gronseth, G., Perlmutter, J., Reich, S., Zesiewicz, T., & Weiner, W. J. (2006) · Neurology · doi:10.1212/01.wnl.0000206363.57955.1b · Cited by 237
Cakit, B. D., Saracoglu, M., Genc, H., Erdem, H. R., & Inan, L. (2007) · Clinical Rehabilitation · doi:10.1177/0269215507077269 · Cited by 229
Giladi, N., Boroojerdi, B., Korczyn, A. D., Burn, D. J., Clarke, C. E., Schapira, A. H. V., & SP513 investigators (2007) · Movement Disorders · doi:10.1002/mds.21741 · Cited by 227
Gallagher, D. A., O'Sullivan, S. S., Evans, A. H., Lees, A. J., & Schrag, A. (2007) · Movement Disorders · doi:10.1002/mds.21611 · Cited by 226
Allen, N. E., Canning, C. G., Sherrington, C., Lord, S. R., Latt, M. D., Close, J. C. T., O'Rourke, S. D., Murray, S. M., & Fung, V. S. C. (2010) · Movement Disorders · doi:10.1002/mds.23082 · Cited by 225
Clozapine improves dyskinesias in Parkinson disease: A double-blind, placebo-controlled study
Durif, F., Debilly, B., Galitzky, M., Morand, D., Viallet, F., Borg, M., Thobois, S., Broussolle, E., & Rascol, O. (2004) · Neurology · doi:10.1212/01.wnl.0000110317.52453.6c · Cited by 224
Self-citationDoes subthalamic nucleus stimulation induce apathy in Parkinson’s disease?
Drapier, D., Drapier, S., Sauleau, P., Haegelen, C., Raoul, S., Biseul, I., Peron, J., Lallement, F., Rivier, I., Reymann, J. M., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0177-0 · Cited by 221
Physical therapy in Parkinson's disease: Evolution and future challenges
Keus, S. H. J., Munneke, M., Nijkrake, M. J., Kwakkel, G., & Bloem, B. R. (2009) · Movement Disorders · doi:10.1002/mds.22141 · Cited by 217
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study
Oertel, W. H., Wolters, E., Sampaio, C., Gimenez‐Roldan, S., Bergamasco, B., Dujardin, M., Grosset, D. G., Arnold, G., Leenders, K. L., Hundemer, H., et al. (2006) · Movement Disorders · doi:10.1002/mds.20724 · Cited by 210
Self-citationDopamine agonist therapy in early Parkinson's disease
Stowe, R., Ives, N., Clarke, C. E., van Hilten, Ferreira, J., Hawker, R. J., Shah, L., Wheatley, K., & Gray, R. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006564.pub2 · Cited by 208
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
Parkinson Study Group CALM Cohort Investigators (2009) · Archives of Neurology · doi:10.1001/archneur.66.1.nct90001 · Cited by 205
Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression
Schuurman, P. R., Bosch, D. A., Merkus, M. P., & Speelman, J. D. (2008) · Movement Disorders · doi:10.1002/mds.22059 · Cited by 197
Morris, M. E., Iansek, R., & Kirkwood, B. (2009) · Movement Disorders · doi:10.1002/mds.22295 · Cited by 189
Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease
Wolf, E., Seppi, K., Katzenschlager, R., Hochschorner, G., Ransmayr, G., Schwingenschuh, P., Ott, E., Kloiber, I., Haubenberger, D., Auff, E., et al. (2010) · Movement Disorders · doi:10.1002/mds.23034 · Cited by 185
Self-citationManagement of Parkinson's disease: An evidence-based review
Lang, A. E., & Lees, A. (2002) · Movement Disorders · doi:10.1002/mds.5554 · Cited by 184
Serotonin and Parkinson's disease: On movement, mood, and madness
Fox, S. H., Chuang, R., & Brotchie, J. M. (2009) · Movement Disorders · doi:10.1002/mds.22473 · Cited by 175
Self-citationTickle‐Degnen, L., Ellis, T., Saint‐Hilaire, M. H., Thomas, C. A., & Wagenaar, R. C. (2010) · Movement Disorders · doi:10.1002/mds.22940 · Cited by 167 · cited 2×
“Tickle-Degnen et al (2010)97 performed an RCT of self-managed rehabilitation for 6 weeks.”
MethodAlvarez, L., Macías, R., Pavón, N., López, G., Rodríguez-Oroz, M., Rodriguez, R., Alvarez, M., Pedroso, I., Teijeiro, J., Fernández, R., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.154948 · Cited by 160
Qigong exercise for the symptoms of Parkinson's disease: A randomized, controlled pilot study
Schmitz‐Hübsch, T., Pyfer, D., Kielwein, K., Fimmers, R., Klockgether, T., & Wüllner, U. (2005) · Movement Disorders · doi:10.1002/mds.20705 · Cited by 157
Waters, C., Sethi, K. D., Hauser, R. A., Molho, E., & Bertoni, J. M. (2004) · Movement Disorders · doi:10.1002/mds.20036 · Cited by 153
Selegiline delays the onset of disability in de novo parkinsonian patients
Pålhagen, S., Heinonen, E. H., Hägglund, J., Kaugesaar, T., Kontants, H., Mäki-Ikola, O., Palm, R., Turunen, J., & *Swedish Parkinson Study Group (1998) · Neurology · doi:10.1212/wnl.51.2.520 · Cited by 149
Sage, M. D., & Almeida, Q. J. (2009) · Movement Disorders · doi:10.1002/mds.22469 · Cited by 149
Body weight gain rate in patients with Parkinson's disease and deep brain stimulation
Barichella, M., Marczewska, A. M., Mariani, C. B., Landi, A., Vairo, A., & Pezzoli, G. (2003) · Movement Disorders · doi:10.1002/mds.10543 · Cited by 147
The Long-Acting Dopamine Receptor Agonist Cabergoline in Early Parkinson???s Disease
Bracco, F., Battaglia, A., Chouza, C., Dupont, E., Gershanik, O. S., Martí-Massó, J. F., & Montastruc, J. (2004) · CNS Drugs · doi:10.2165/00023210-200418110-00003 · Cited by 144
Möller, J. C., Oertel, W., Köster, J., Pezzoli, G., & Provinciali, L. (2005) · Movement Disorders · doi:10.1002/mds.20397 · Cited by 135
Burini, D., Farabollini, B., Iacucci, S., Rimatori, C., Riccardi, G. R., Capecci, M., Provinciali, L., & Ceravolo, M. G. (2006) · PubMed · Cited by 134
Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease
Klostermann, F., Ehlen, F., Vesper, J., Nubel, K., Gross, M., Marzinzik, F., Curio, G., & Sappok, T. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.123323 · Cited by 132
Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight
Macia, F., Perlemoine, C., Coman, I., Guehl, D., Burbaud, P., Cuny, E., Gin, H., Rigalleau, V., & Tison, F. (2003) · Movement Disorders · doi:10.1002/mds.10630 · Cited by 124
Hauser, R. A., Panisset, M., Abbruzzese, G., Mancione, L., Dronamraju, N., Kakarieka, A., & on behalf of the FIRST‐STEP Study Group (2008) · Movement Disorders · doi:10.1002/mds.22343 · Cited by 122
Alberts, J. L., Voelcker‐Rehage, C., Hallahan, K., Vitek, M., Bamzai, R., & Vitek, J. L. (2008) · Brain · doi:10.1093/brain/awn238 · Cited by 122
Stern, M. B., MAREK, K. L., Friedman, J. H., Hauser, R. A., LeWitt, P. A., Tarsy, D., & Olanow, C. W. (2004) · Movement Disorders · doi:10.1002/mds.20145 · Cited by 118
Novel Therapeutic Effects of the Anti-Convulsant, Zonisamide, on Parkinsons Disease
Murata, M. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453180 · Cited by 108
Olanow, C. W. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1563 · Cited by 106
Hauser, R., Schapira, A., Rascol, O., Barone, P., Mizuno, Y., Salin, L., Haaksma, M., Juhel, N., & Poewe, W. (2010) · Movement Disorders · doi:10.1002/mds.23317 · Cited by 105
Self-citationStowe, R. L., Ives, N. J., Clarke, C. E., Deane, K. H., van Hilten, Wheatley, K., Gray, R. G., Handley, K., & Furmston, A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007166.pub2 · Cited by 103
Kurtaiş, Y., Kutlay, Ş., Tur, B. S., Gök, H., & Akbostancı, C. (2008) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0b013e318170626d · Cited by 101
Stocchi, F., Hersh, B. P., Scott, B. L., Nausieda, P. A., Giorgi, L., & on Behalf of the EASE-PD Monotherapy Study Investigators (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802387130 · Cited by 100
The Behavioral Complications of Pallidal Stimulation: A Case Report
Miyawaki, E. K., Perlmutter, J. S., Tröster, A. I., Videen, T. O., & Koller, W. C. (2000) · Brain and Cognition · doi:10.1006/brcg.1999.1113 · Cited by 94
Watts, R., Lyons, K., Pahwa, R., Sethi, K., Stern, M., Hauser, R. A., Olanow, W., Gray, A., Adams, B. E., & Earl, N. (2010) · Movement Disorders · doi:10.1002/mds.22890 · Cited by 92
Effectiveness of acupuncture for Parkinson's disease: A systematic review
Lee, M. S., Shin, B., Kong, J. C., & Ernst, E. (2008) · Movement Disorders · doi:10.1002/mds.21993 · Cited by 91
Cardiac and noncardiac fibrotic reactions caused by ergot‐and nonergot‐derived dopamine agonists
Andersohn, F., & Garbe, E. (2008) · Movement Disorders · doi:10.1002/mds.22385 · Cited by 75
Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study
Rascol, O., Dubois, B., Castro‐Caldas, A., Senn, S. J., Signore, S. D., & Lees, A. J. (2006) · Movement Disorders · doi:10.1002/mds.21122 · Cited by 72
Self-citationChanges in Walking Activity and Endurance Following Rehabilitation for People With Parkinson Disease
White, D. K., WAGENAAR, R. C., Ellis, T. D., & Tickle‐Degnen, L. (2009) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2008.06.034 · Cited by 71
Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
Herd, C. P., Tomlinson, C. L., Deane, K. H., Brady, M., Smith, C. H., Sackley, C. M., & Clarke, C. E. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002814 · Cited by 70
Reichmann, H., Boas, J., MacMahon, D. G., Myllylä, V. V., Hakala, A., Reinikainen, K. J., & on behalf of the ComQol Study Group (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00363.x · Cited by 67
Merello, M., Tenca, E., Lloret, S. P., Martín, M. E., Bruno, V., Cavanagh, S., Antico, J., Cerquetti, D., & Leiguarda, R. (2008) · British Journal of Neurosurgery · doi:10.1080/02688690801971667 · Cited by 64
Simonis, G., Fuhrmann, J. T., & Strasser, R. H. (2007) · Movement Disorders · doi:10.1002/mds.21639 · Cited by 57
Castro‐Caldas, A., Delwaide, P. J., Jost, W. H., Merello, M., Williams, A. C., Lamberti, P., Aguilar, M., Signore, S. D., & Césaro, P. (2005) · Movement Disorders · doi:10.1002/mds.20750 · Cited by 56
Bromocriptine use and the risk of valvular heart disease
Tan, L. C. S., Ng, K. K. C., Au, W., Lee, R. K. K., Chan, Y., & Tan, N. C. (2008) · Movement Disorders · doi:10.1002/mds.22228 · Cited by 53
Diagnosis and management of pergolide‐induced fibrosis
Agarwal, P., Fahn, S., & Frucht, S. J. (2004) · Movement Disorders · doi:10.1002/mds.20200 · Cited by 52
Esselink, R. A. J., de Bie, R. M. A., de Haan, R. J., Steur, E. N. H. J., Beute, G. N., Portman, A. T., Schuurman, P. R., Bosch, D. A., & Speelman, J. D. (2006) · Acta Neurochirurgica · doi:10.1007/s00701-006-0907-1 · Cited by 49
Kieburtz, K. D., & The Parkinson Study Group PramiBID Investigators (2010) · Movement Disorders · doi:10.1002/mds.23396 · Cited by 47
Skin cancer and Parkinson's disease
Ferreira, J. J., Neutel, D., Mestre, T., Coelho, M. M., Rosa, M. M., Rascol, O., & Sampaio, C. (2010) · Movement Disorders · doi:10.1002/mds.22855 · Cited by 47
Self-citationMizuno, Y., Abe, T., Hasegawa, K., Kuno, S., Kondo, T., Yamamoto, M., Nakashima, M., Kanazawa, I., & STRONG Study Group (2007) · Movement Disorders · doi:10.1002/mds.21313 · Cited by 47
Downhill Walking Training in Individuals with Parkinson's Disease: A Randomized Controlled Trial
Yang, Y., Lee, Y., Cheng, S., & Wang, R. (2010) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181e721c5 · Cited by 46
Hypersexuality after pallidal surgery in Parkinson disease.
Roane, D. M., Yu, M., Feinberg, T. E., & Rogers, J. (2002) · PubMed · Cited by 46
Ondo, W. G., Sethi, K. D., & Kricorian, G. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3180616570 · Cited by 44
Kubo, S., Iwatake, A., Ebihara, N., Murakami, A., & Hattori, N. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.03.003 · Cited by 43
Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's disease
Lees, A. J., Ratziu, V., Tolosa, E., & Oertel, W. H. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.097154 · Cited by 43
Barone, P., Lamb, J., Ellis, A., & Clarke, Z. (2007) · Movement Disorders · doi:10.1002/mds.21191 · Cited by 42
Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone
Fung, V. S. C., Herawati, L., Wan, Y., & on behalf of the QUEST‐AP Study Group (2008) · Movement Disorders · doi:10.1002/mds.21878 · Cited by 42
Mizuno, Y., Kanazawa, I., Kuno, S., Yanagisawa, N., Yamamoto, M., Kondo, T., & Japanese Parkinson–Entacapone Study Group (2006) · Movement Disorders · doi:10.1002/mds.21218 · Cited by 40
Stocchi, F., Fabbri, L., Vécsei, L., Krygowska‐Wajs, A., Preti, P. A. M., & Ruggieri, S. A. (2007) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000236762.77913.c6 · Cited by 39
Deuschl, G., Vaitkus, A., Fox, G., Roscher, T., Schremmer, D., & Gordin, A. (2007) · Movement Disorders · doi:10.1002/mds.21473 · Cited by 34
Singer, C., Lamb, J., Ellis, A., & Layton, G. (2007) · Movement Disorders · doi:10.1002/mds.21361 · Cited by 31
Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia
Graff-Radford, J., Foote, K. D., Rodriguez, R. L., Fernandez, H. H., Hauser, R. A., Sudhyadhom, A., Rosado, C. A., Sanchez, J. C., & Okun, M. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.1181 · Cited by 30
LONG-TERM SUPERIORITY OF SUBTHALAMIC NUCLEUS STIMULATION OVER PALLIDOTOMY IN PARKINSON DISEASE
Esselink, R. A. J., de Bie, R. M. A., de Haan, R. J., Lenders, M. W. P. M., Nijssen, P. C. G., van Laar, T., Schuurman, P. R., Bosch, D. A., & Speelman, J. D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ad536c · Cited by 30
Çoban, A., Hanağası, H., Karamürsel, S., & Barlas, O. (2009) · British Journal of Neurosurgery · doi:10.1080/02688690802507775 · Cited by 27
Stocchi, F., Zappia, M., Dall’Armi, V., et al. (2010) · Movement Disorders · doi:10.1002/mds.23206 · Cited by 24
Trial of subtherapeutic pergolide in de novo Parkinson's disease
Grosset, K. A., Grosset, D. G., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20361 · Cited by 13
Clinical observation of combined acupuncture and herbs in treating Parkinson’s disease
Huang, W., Xi, G.-F., & Hua, X.-G. (2008) · Journal of Acupuncture and Tuina Science · doi:10.1007/s11726-009-0033-8 · Cited by 10
(2001) · doi:10.1002/1531-8257(200101)16:1<79::aid-mds1013>3.0.co;2-h
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Self-citationBalestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Neurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
Seppi, K., Ray Chaudhuri, K., Coelho, M., Fox, S. H., Katzenschlager, R., Perez Lloret, S., Weintraub, D., Sampaio, C., & and the collaborators of the Parkinson's Disease Update on Non‐Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence‐Based Medicine Committee (2019) · Movement Disorders · doi:10.1002/mds.27602 · Cited by 1,007
Self-citation
Metadata
- Authors
- Fox, S. H., Katzenschlager, R., Lim, S., Ravina, B., Seppi, K., Coelho, M., Poewe, W., Rascol, O., Goetz, C. G., & Sampaio, C.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2011-10
- Volume
- 26
- Issue
- S3
- Pages
- S2-41
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W4211223857
- Cited by
- 523
- References
- 116
- FWCI
- 23.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.